Cargando…
A point-prevalence study of off-label medication use in an Australian adult tertiary intensive care unit
Medications prescribed for indications or at doses, frequencies or durations not approved by the Australian Therapeutic Goods Administration are considered “off- label”. Critical illness makes seeking consent for off-label medication use impractical. We aimed to characterise the extent of off-label...
Autores principales: | Wiebe, Jordan, Lipman, Jeffrey, Reade, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692588/ https://www.ncbi.nlm.nih.gov/pubmed/38045597 http://dx.doi.org/10.51893/2022.2.OA8 |
Ejemplares similares
-
A multicentre point prevalence study of delirium assessment and management in patients admitted to Australian and New Zealand intensive care units
por: Ankravs, Melissa J., et al.
Publicado: (2023) -
Comment: Is off-label medication use in the ICU a problem?
por: Cotta, Menino O., et al.
Publicado: (2023) -
USE OF OFF-LABEL MEDICATIONS IN A NEONATAL INTENSIVE CARE UNIT
por: Koszma, Erica Inez Alves, et al.
Publicado: (2021) -
Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit
por: dos Santos, Laura Goedel, et al.
Publicado: (2023) -
Off-label prescriptions in intensive care unit: the Chinese experience
por: Liu, Lin, et al.
Publicado: (2018)